Beyond Air, Inc. (XAIR) stock
XAIRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3086% below fair value
$1.72−0.13 (-7.03%)
Close on Nov 19, 2026Market cap $1.65MP/E –Yield –
Beyond Air operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Beyond Air's operating income for the twelve months ending Jun 30, 2026 was -$28.04M. For fiscal 2026 it was -$29.04M. The highest annual figure on record is $2.33M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$29.04M | – |
| FY2025 | Mar 31, 2025 | -$44.54M | – |
| FY2024 | Mar 31, 2024 | -$63.01M | – |
| FY2023 | Mar 31, 2023 | -$52.06M | – |
| FY2022 | Mar 31, 2022 | -$40.71M | – |
| FY2021 | Mar 31, 2021 | -$22.21M | – |
| FY2020 | Mar 31, 2020 | -$18.14M | – |
| FY2017 | Dec 31, 2017 | -$11.07M | -574.4% |
| FY2016 | Dec 31, 2016 | $2.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$6.61M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$7.17M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$6.60M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$7.66M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$7.62M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$7.17M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$10.95M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$12.83M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$13.58M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$12.63M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$16.96M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$17.54M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$15.88M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$13.99M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$14.01M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$12.62M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$11.44M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$20.43M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$7.49M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$6.20M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$6.59M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$5.03M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$5.62M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$4.97M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$6.60M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$5.26M | -321.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$4.74M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$4.27M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$3.88M | -208.8% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $2.38M | -41.3% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$2.06M | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -$3.07M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $3.57M | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $4.05M | – |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | -$167.00K | – |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | -$626.00K | – |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | -$923.00K | – |
See a number that looks wrong?